Does heavy menstrual bleeding cause iron deficiency reflected by low ferritin, low transferrin saturation, and hypochromic red-cell indices?

Heavy menstrual bleeding (HMB) is a primary driver of iron deficiency in women of reproductive age, as the rate of iron loss through excessive blood volume often exceeds the body's capacity for dietary absorption. Because iron is a core component of hemoglobin, chronic blood loss systematically exhausts physiological stores and impairs the production of healthy red blood cells.

Clinical and effectiveness evidence

Heavy menstrual bleeding, typically defined as blood loss exceeding 80 mL per cycle, results in a significant loss of iron—approximately 0.5 mg per milliliter of blood. While normal menses result in the loss of 15–25 mg of iron, HMB can cause losses of 40 mg or more per cycle.

• Prevalence: Research across clinical cohorts shows that 30% to 52% of women with HMB suffer from iron deficiency, and up to 58% may progress to iron deficiency anemia (IDA).
• Diagnostic Thresholds: Medical guidelines generally identify iron deficiency in these patients when serum ferritin levels fall below 30–40 μg/L. Clinical studies confirm that self-reported heavy bleeding is a highly reliable predictor of both low ferritin and low hemoglobin levels.

Mechanistic explanations

The progression from blood loss to anemia follows a predictable physiological sequence:

• Depletion of Stores (Ferritin): To compensate for blood loss, the body mobilizes iron from its primary storage protein, ferritin. As these stores are exhausted, serum ferritin levels drop, serving as the most sensitive early marker for absolute iron deficiency.
• Functional Iron Deficiency (TSAT): Once stores are depleted, the supply of iron to the plasma decreases. Transferrin saturation (TSAT)—the ratio of circulating iron to the total iron-binding capacity—subsequently falls. A TSAT level below 20% indicates that there is insufficient iron available for the bone marrow to produce new red blood cells (erythropoiesis).
• Hypochromic Indices: Iron is essential for synthesizing heme. When iron is scarce, erythroid precursors cannot produce enough hemoglobin. This results in "hypochromic" red blood cells—cells that contain less hemoglobin than normal. This is measured clinically through low Mean Corpuscular Hemoglobin (MCH) and Mean Corpuscular Hemoglobin Concentration (MCHC) indices.

Clinical implications

For practitioners and patients, the presence of low ferritin and low TSAT alongside hypochromic indices (low MCH/MCHC) provides a highly specific diagnostic profile for iron deficiency. Because ferritin can be elevated by inflammation, the concurrent measurement of TSAT is critical for confirming that the deficiency is driving impaired red cell production.

Bottom line

Heavy menstrual bleeding is a major cause of iron deficiency; the condition is characterized by a sequential depletion of iron stores (low ferritin) and circulating iron (low transferrin saturation), eventually leading to the production of under-hemoglobinized, pale red blood cells (hypochromia).